SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
xymm1204
Lv1
1
40 积分
2023-09-12 加入
最近求助
最近应助
互助留言
Antioxidants and the risk of metabolic dysfunction-associated steatotic liver disease: results of National Health and Nutrition Examination Survey and two-sample Mendelian randomization analyses
5小时前
待确认
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
3个月前
已完结
The role of cytokines as predictors for NAFLD-related diseases: a bidirectional Mendelian randomization study
3个月前
已完结
Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice
3个月前
已完结
Tirzepatide, a dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β‐cells and hepatic steatosis in obese type 2 diabetic db/db mice
3个月前
已完结
Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice
4个月前
已完结
Tirzepatide’s role in targeting adipose tissue macrophages to reduce obesity-related inflammation and improve insulin resistance
4个月前
已完结
Patients with type 2 diabetes who achieve reduced postprandial glucose levels during insulin intensive therapy may have a better recovery of β-cell function
4个月前
已完结
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
6个月前
已完结
Changes in lean body mass with glucagon‐like peptide‐1‐based therapies and mitigation strategies
6个月前
已完结
没有进行任何应助
无人应答【积分已退回】
1年前
标题错误 DOI错误
1年前
谢谢!速度真快,帮大忙了!
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论